Document ID: chunk:federal_register_of_legislation:F2024C00988:clause:1_8:p2
Version: federal_register_of_legislation:F2024C00988
Segment Type: clause
Provision Reference: sch 1 cl 8 (pt 2/3)
Character Range: 176937–181917

have  renum = renumbered
effect                                          rep = repealed
F = Federal Register of Legislation             rs = repealed and substituted
gaz = gazette                                   s = section(s)/subsection(s)
LA = Legislation Act 2003                       Sch = Schedule(s)
LIA = Legislative Instruments Act 2003          Sdiv = Subdivision(s)
(md) = misdescribed amendment can be given      SLI = Select Legislative Instrument
effect                                          SR = Statutory Rules
(md not incorp) = misdescribed amendment        Sub‑Ch = Sub‑Chapter(s)
cannot be given effect                          SubPt = Subpart(s)
mod = modified/modification                     underlining = whole or part not
No. = Number(s)                                 commenced or to be commenced

Endnote 3—Legislation history

Name                                                                                                                                                      Registration                Commencement                                      Application, saving and transitional provisions
National Health (Pharmaceutical Benefits) Regulations 2017                                                                                                27 Mar 2017 (F2017L00313)   1 Apr 2017 (s 2(1) item 1)
National Health (Pharmaceutical Benefits) Amendment (Safety Net) Regulations 2018                                                                         16 May 2018 (F2018L00621)   1 June 2018 (s 2(1) item 1)                       —
National Health (Pharmaceutical Benefits) Amendment (Electronic Prescriptions) Regulations 2019                                                           16 Aug 2019 (F2019L01072)   31 Oct 2019 (s 2(1) item 1)                       —
National Health (Pharmaceutical Benefits) Amendment (Active Ingredient Prescribing) Regulations 2019                                                      9 Oct 2019 (F2019L01312)    31 Oct 2019 (s 2(1) item 1)                       —
National Health (Pharmaceutical Benefits) Amendment (Supply of Pharmaceutical Benefits Following Bankruptcy or External Administration) Regulations 2019  29 Nov 2019 (F2019L01530)   5 Dec 2019 (s 2(1) item 1)                        —
National Health (Pharmaceutical Benefits) Amendment (Seventh Community Pharmacy Agreement) Regulations 2020                                               9 July 2020 (F2020L00898)   10 July 2020 (s 2(1) item 1)                      —
National Health (Pharmaceutical Benefits) Amendment (Active Ingredient Prescribing) Regulations 2020                                                      25 Aug 2020 (F2020L01055)   26 Aug 2020 (s 2(1) item 1)                       —
National Health (Pharmaceutical Benefits) Amendment (Electronic Prescribing) Regulations 2021                                                             3 June 2021 (F2021L00687)   4 June 2021 (s 2(1) item 1)                       —
National Health (Pharmaceutical Benefits) Amendment (2021 Measures No. 1) Regulations 2021                                                                16 Dec 2021 (F2021L01797)   Sch 1 (items 1–3): 1 July 2022 (s 2(1) item 2)    —
                                                                                                                                                                                      Sch 1 (items 4–7): 1 Oct 2022 (s 2(1) item 3)
                                                                                                                                                                                      Sch 1 (items 8–12): 1 Apr 2023 (s 2(1) item 4)
                                                                                                                                                                                      Sch 1 (items 13–15): 1 July 2023 (s 2(1) item 5)
National Health (Pharmaceutical Benefits) Amendment (2024 Measures No. 1) Regulations 2024                                                                28 Mar 2024 (F2024L00380)   1 Apr 2024 (s 2(1) item 1)                        —
National Health (Pharmaceutical Benefits) Amendment (Eighth Community Pharmacy Agreement) Regulations 2024                                                28 June 2024 (F2024L00830)  1 July 2024 (s 2(1) item 1)                       —
National Health (Pharmaceutical Benefits) Amendment (Medication Charts) Regulations 2024                                                                  1 Oct 2024 (F2024L01241)    2 Oct 2024 (s 2(1) item 1)                        —
Administrative Review Tribunal Legislation Consequential Amendments (2024 Measures No. 1) Regulations 2024                                                11 Oct 2024 (F2024L01299)   Sch 7 (items 13–16): 14 Oct 2024 (s 2(1) item 1)  —

Endnote 4—Amendment history

Provision affected           How affected
Part 1
Division 1
s 2.....................     rep LA s 48D